Skip to main content
Erschienen in: Virchows Archiv 3/2022

12.07.2022 | Original Article

Computational portraits of the tumoral microenvironment in human breast cancer

verfasst von: Dongling Wu, Sean M. Hacking, Hector Chavarria, Mohammed Abdelwahed, Mansoor Nasim

Erschienen in: Virchows Archiv | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer is the most diagnosed cancer in humans. In recent years, myxoid and proportionated stroma have been described as clinically significant in many cancer subtypes. Here computational portraits of tumor-associated stromata were created from a machine learning (ML) classifier using QuPath to evaluate proportionated stromal area (PSA), myxoid stromal ratio (MSR), and immune stroma proportion (ISP) from whole slide images (WSI). The ML classifier was validated in independent training (n = 40) and validation (n = 109) cohorts finding MSR, PSA, and ISP to be associated with tumor stage, lymph node status, Nottingham grade, stromal differentiation (SD), tumor size, estrogen receptor (ER), progesterone receptor (PR), and receptor tyrosine-protein kinase erbB-2 (HER-2). Overall, MSR correlated better with the clinicopathologic profile than PSA and ISP. High MSR was found to be associated with high tumor stage, low ISP, and high Nottingham histologic score. As a computational biomarker, high MSR was more likely to be associated with luminal B like, Her-2 enriched, and triple-negative biomarker status when compared to luminal A like. The supervised ML superpixel approach demonstrated here can be performed by a trained pathologist to provide a faster and more uniformed approach to the analysis to the tumoral microenvironment (TME). The TME may be relevant for clinical decision-making, determining chemotherapeutic efficacy, and guiding a more overall precision-based breast cancer care.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lukasiewicz SCM, Forma A et al (2021) Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review. Cancers MDPI 13:17 Lukasiewicz SCM, Forma A et al (2021) Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review. Cancers MDPI 13:17
2.
Zurück zum Zitat KDA Aysola, C Welch, J Xu, Y Qin, V Reddy, R Matthews, C Owens, J Okoli, D Beech, C Piyathilake, S Reddy, V Rao 2013 Triple negative breast cancer - an overview. Hereditary Genet, 2013. KDA Aysola, C Welch, J Xu, Y Qin, V Reddy, R Matthews, C Owens, J Okoli, D Beech, C Piyathilake, S Reddy, V Rao 2013 Triple negative breast cancer - an overview. Hereditary Genet, 2013.
3.
Zurück zum Zitat Henke E, Nandigama R, Ergün S (2020) Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Frontiers in Molecular Biosciences 6:160CrossRef Henke E, Nandigama R, Ergün S (2020) Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Frontiers in Molecular Biosciences 6:160CrossRef
4.
Zurück zum Zitat Kramer CVK, Pelt G, Dekker T (2019) The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review. Breast Cancer Res Treat 173:55–64CrossRef Kramer CVK, Pelt G, Dekker T (2019) The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review. Breast Cancer Res Treat 173:55–64CrossRef
5.
Zurück zum Zitat de Kruijf EM, van Nes JGH, van de Velde CJH, Putter H (2011) Smit VTHBM, Liefers GJ, Kuppen PJK, Tollenaar RAEM, Mesker WE: Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Res Treat 125(3):687–696CrossRef de Kruijf EM, van Nes JGH, van de Velde CJH, Putter H (2011) Smit VTHBM, Liefers GJ, Kuppen PJK, Tollenaar RAEM, Mesker WE: Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Res Treat 125(3):687–696CrossRef
6.
Zurück zum Zitat Guedj N, Blaise L, Cauchy F, Albuquerque M, Soubrane O, Paradis V (2021) Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma. Mod Pathol 34(2):408–416CrossRef Guedj N, Blaise L, Cauchy F, Albuquerque M, Soubrane O, Paradis V (2021) Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma. Mod Pathol 34(2):408–416CrossRef
7.
Zurück zum Zitat Cao L, Sun P-L, He Y, Yao M, Gao H (2020) Desmoplastic reaction and tumor budding in cervical squamous cell carcinoma are prognostic factors for distant metastasis: a retrospective study. Cancer Manag Res 12:137–144CrossRef Cao L, Sun P-L, He Y, Yao M, Gao H (2020) Desmoplastic reaction and tumor budding in cervical squamous cell carcinoma are prognostic factors for distant metastasis: a retrospective study. Cancer Manag Res 12:137–144CrossRef
8.
Zurück zum Zitat Kemi NA, Eskuri M, Pohjanen V-M, Karttunen TJ, Kauppila JH (2019) Histological assessment of stromal maturity as a prognostic factor in surgically treated gastric adenocarcinoma. Histopathology 75(6):882–889CrossRef Kemi NA, Eskuri M, Pohjanen V-M, Karttunen TJ, Kauppila JH (2019) Histological assessment of stromal maturity as a prognostic factor in surgically treated gastric adenocarcinoma. Histopathology 75(6):882–889CrossRef
9.
Zurück zum Zitat Hacking SM, Chakraborty B, Nasim R, Vitkovski T, Thomas R (2021) A holistic appraisal of stromal differentiation in colorectal cancer: biology, histopathology, computation, and genomics. Pathology - Research and Practice 220:153378CrossRef Hacking SM, Chakraborty B, Nasim R, Vitkovski T, Thomas R (2021) A holistic appraisal of stromal differentiation in colorectal cancer: biology, histopathology, computation, and genomics. Pathology - Research and Practice 220:153378CrossRef
10.
Zurück zum Zitat Ueno H, Ishiguro M, Nakatani E, Ishikawa T, Uetake H, Murotani K, Matsui S, Teramukai S, Sugai T, Ajioka Y et al: Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial). British Journal of Cancer 2021. Ueno H, Ishiguro M, Nakatani E, Ishikawa T, Uetake H, Murotani K, Matsui S, Teramukai S, Sugai T, Ajioka Y et al: Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial). British Journal of Cancer 2021.
11.
Zurück zum Zitat Hacking SM, Wu D, Alexis C, Nasim M (2022) A novel superpixel approach to the tumoral microenvironment in colorectal cancer. Journal of Pathology Informatics 13:100009CrossRef Hacking SM, Wu D, Alexis C, Nasim M (2022) A novel superpixel approach to the tumoral microenvironment in colorectal cancer. Journal of Pathology Informatics 13:100009CrossRef
12.
Zurück zum Zitat Millar EK, Browne LH, Beretov J, Lee K, Lynch J, Swarbrick A, Graham PH (2020) Tumour stroma ratio assessment using digital image analysis predicts survival in triple negative and luminal breast cancer. Cancers (Basel) 12:12 Millar EK, Browne LH, Beretov J, Lee K, Lynch J, Swarbrick A, Graham PH (2020) Tumour stroma ratio assessment using digital image analysis predicts survival in triple negative and luminal breast cancer. Cancers (Basel) 12:12
13.
Zurück zum Zitat Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M et al (2010) American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer. Arch Pathol Lab Med 134(6):907–922CrossRef Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M et al (2010) American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer. Arch Pathol Lab Med 134(6):907–922CrossRef
14.
Zurück zum Zitat Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P, Hanna W et al (2018) Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Arch Pathol Lab Med 142(11):1364–1382CrossRef Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P, Hanna W et al (2018) Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Arch Pathol Lab Med 142(11):1364–1382CrossRef
15.
Zurück zum Zitat Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG et al (2017) QuPath: Open source software for digital pathology image analysis. Sci Rep 7(1):16878CrossRef Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG et al (2017) QuPath: Open source software for digital pathology image analysis. Sci Rep 7(1):16878CrossRef
16.
Zurück zum Zitat R. Salgado CD, S. Demaria, N. Sirtaine, F. Klauschen, G. Pruneri, S.Wienert, G. Van den Eynden, F. L. Baehner, F. Penault-Llorca, E. A. Perez, E. A. Thompson, W. F. Symmans, A. L. Richardson, J. Brock, C. Criscitiello, H. Bailey, M. Ignatiadis, G. Floris, J. Sparano, Z. Kos, T. Nielsen, D. L. Rimm, K. H. Allison, J. S. Reis-Filho, S. Loibl, C. Sotiriou, G. Viale, S. Badve, S. Adams, K. Willard-Gallo, S. Loi 2014 The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Annals of Oncology, 26. R. Salgado CD, S. Demaria, N. Sirtaine, F. Klauschen, G. Pruneri, S.Wienert, G. Van den Eynden, F. L. Baehner, F. Penault-Llorca, E. A. Perez, E. A. Thompson, W. F. Symmans, A. L. Richardson, J. Brock, C. Criscitiello, H. Bailey, M. Ignatiadis, G. Floris, J. Sparano, Z. Kos, T. Nielsen, D. L. Rimm, K. H. Allison, J. S. Reis-Filho, S. Loibl, C. Sotiriou, G. Viale, S. Badve, S. Adams, K. Willard-Gallo, S. Loi 2014 The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Annals of Oncology, 26.
17.
Zurück zum Zitat Kurozumi SMH, Kurosumi M, Inoue K, Fujii T, Horiguchi J, Shirabe K, Oyama T, Kuwano H (2019) Prognostic significance of tumour-infiltrating lymphocytes for oestrogen receptor-negative breast cancer without lymph node metastasis. Oncol Letters 17(2647):2656 Kurozumi SMH, Kurosumi M, Inoue K, Fujii T, Horiguchi J, Shirabe K, Oyama T, Kuwano H (2019) Prognostic significance of tumour-infiltrating lymphocytes for oestrogen receptor-negative breast cancer without lymph node metastasis. Oncol Letters 17(2647):2656
18.
Zurück zum Zitat Mesker WJJ, Szuhai K, Heer P, Morreau H, Tanke H, Tollenaar R (2007) The carcinoma stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cellular Oncology 29(2007):387–398PubMedPubMedCentral Mesker WJJ, Szuhai K, Heer P, Morreau H, Tanke H, Tollenaar R (2007) The carcinoma stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cellular Oncology 29(2007):387–398PubMedPubMedCentral
19.
Zurück zum Zitat van Pelt GW, Sandberg TP, Morreau H, Gelderblom H, van Krieken J, Tollenaar R, Mesker WE (2018) The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact. Histopathology 73(2):197–206CrossRef van Pelt GW, Sandberg TP, Morreau H, Gelderblom H, van Krieken J, Tollenaar R, Mesker WE (2018) The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact. Histopathology 73(2):197–206CrossRef
20.
Zurück zum Zitat van Pelt GKJ, Lips I, Peters F, van Klaveren D, Boonstra J, de Steur W, Tollenaar RSA, Mesker W, Slingerland M (2020) The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer. Clinical and Transliational Radiation Oncology 20(39):44 van Pelt GKJ, Lips I, Peters F, van Klaveren D, Boonstra J, de Steur W, Tollenaar RSA, Mesker W, Slingerland M (2020) The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer. Clinical and Transliational Radiation Oncology 20(39):44
21.
Zurück zum Zitat Moorman A VR, Heijmans H, van der Palen J, Kouwenhoven E 2012 The prognostic value of tumour-stroma ratio in triple-negative breast cancer. Eur J Surg Oncol. Moorman A VR, Heijmans H, van der Palen J, Kouwenhoven E 2012 The prognostic value of tumour-stroma ratio in triple-negative breast cancer. Eur J Surg Oncol.
22.
Zurück zum Zitat Yanai H Yk, Ishida M, Tsuta K, Sekimoto M, Sugie T 2021 Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study. Plos One. Yanai H Yk, Ishida M, Tsuta K, Sekimoto M, Sugie T 2021 Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study. Plos One.
23.
Zurück zum Zitat Zhai QFJ, Lin Q, Liu X, Li J, Hong R, Wang S (2019) Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer. Plos One 14(10):e0223325CrossRef Zhai QFJ, Lin Q, Liu X, Li J, Hong R, Wang S (2019) Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer. Plos One 14(10):e0223325CrossRef
24.
Zurück zum Zitat Li B PG, Yao J, Ding Q, Jia P, Zhao Z 2021 Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types. Oncogene, 40. Li B PG, Yao J, Ding Q, Jia P, Zhao Z 2021 Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types. Oncogene, 40.
25.
Zurück zum Zitat Winslow SLK, Edsjo A, Larsson C (2016) The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer. BMC Cancer 16:841CrossRef Winslow SLK, Edsjo A, Larsson C (2016) The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer. BMC Cancer 16:841CrossRef
26.
Zurück zum Zitat Stanton SE, Adams S, Disis ML (2016) Variation in the incidence and magnitude of tumor-infiltrating lymphocytes in breast cancer subtypes: a systematic review. JAMA Oncol 2(10):1354–1360CrossRef Stanton SE, Adams S, Disis ML (2016) Variation in the incidence and magnitude of tumor-infiltrating lymphocytes in breast cancer subtypes: a systematic review. JAMA Oncol 2(10):1354–1360CrossRef
27.
Zurück zum Zitat Ahn SCY, Soo A, Kim M, Woo J, Park S (2020) Changes and prognostic values of tumor- infiltrating lymphocyte subsets after primary systemic therapy in breast cancer. PLoS ONE 15(5):e0233037CrossRef Ahn SCY, Soo A, Kim M, Woo J, Park S (2020) Changes and prognostic values of tumor- infiltrating lymphocyte subsets after primary systemic therapy in breast cancer. PLoS ONE 15(5):e0233037CrossRef
28.
Zurück zum Zitat Kos Z (2020) Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer. npj Breast Cancer 6:17CrossRef Kos Z (2020) Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer. npj Breast Cancer 6:17CrossRef
29.
Zurück zum Zitat Sarker IH (2021) Machine learning: algorithms, real-world applications and research directions. SN Computer Science 2(3):160CrossRef Sarker IH (2021) Machine learning: algorithms, real-world applications and research directions. SN Computer Science 2(3):160CrossRef
31.
Zurück zum Zitat Berardi VL, Zhang GP (2003) An empirical investigation of bias and variance in time series forecasting: modeling considerations and error evaluation. IEEE Trans Neural Netw 14(3):668–679CrossRef Berardi VL, Zhang GP (2003) An empirical investigation of bias and variance in time series forecasting: modeling considerations and error evaluation. IEEE Trans Neural Netw 14(3):668–679CrossRef
32.
33.
Zurück zum Zitat Geman S, Bienenstock E, Doursat R (1992) Neural networks and the bias/variance dilemma. Neural Comput 4:1–58CrossRef Geman S, Bienenstock E, Doursat R (1992) Neural networks and the bias/variance dilemma. Neural Comput 4:1–58CrossRef
34.
Zurück zum Zitat Berardi V, Zhang P (2003) An empirical investigation of bias and variance in time series forecasting: modeling considerations and error evaluation IEEE transactions on neural networks / a publication of the IEEE. Neural Networks Council 14:668–679CrossRef Berardi V, Zhang P (2003) An empirical investigation of bias and variance in time series forecasting: modeling considerations and error evaluation IEEE transactions on neural networks / a publication of the IEEE. Neural Networks Council 14:668–679CrossRef
35.
Zurück zum Zitat Shi C, Pun C-M (2018) Superpixel-based 3D deep neural networks for hyperspectral image classification. Pattern Recogn 74:600–616CrossRef Shi C, Pun C-M (2018) Superpixel-based 3D deep neural networks for hyperspectral image classification. Pattern Recogn 74:600–616CrossRef
Metadaten
Titel
Computational portraits of the tumoral microenvironment in human breast cancer
verfasst von
Dongling Wu
Sean M. Hacking
Hector Chavarria
Mohammed Abdelwahed
Mansoor Nasim
Publikationsdatum
12.07.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 3/2022
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-022-03376-7

Weitere Artikel der Ausgabe 3/2022

Virchows Archiv 3/2022 Zur Ausgabe

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …